?

Can patient-derived iPSC models define responder subgroups for Kv4/KChIP-modulatory therapies?

active
open question Created: 2026-04-25T20:27:03 By: backfill_open_questions Quality: 50% ✓ SciDEX ID: open_question-fca70b29-968b-4bf8-a816-7a
Open Question open Wiki: proteins-kcnip1-protein
Can patient-derived iPSC models define responder subgroups for Kv4/KChIP-modulatory therapies?
Importance Elo
1500
Field Rank
Rank #329 in proteins
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page proteins-kcnip1-protein
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
proteins
Metadata
statusopen
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:27:03.011901'}
field_tagproteins
source_idproteins-kcnip1-protein
sub_fieldkcnip1-protein
source_kindwiki
question_hashf133d9431cfaab83f78e716c8d1d2eda0d8166a686e65a8d646f8c86f72326ac
question_textCan patient-derived iPSC models define responder subgroups for Kv4/KChIP-modulatory therapies?
importance_elo1500
_schema_version1
evidence_summaryExtracted from wiki page proteins-kcnip1-protein
tractability_score0.5
potential_impact_score0.5
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.